Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135080) titled 'Clinical research on the integrated diagnosis and treatment of lung cancer based on targeted FAP' on Oct. 23.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Condition:
Lung cancer
Recruitment Status: Recruiting
Phase: 1-2
Date of First Enrollment: 2025-09-08
Target Sample Size: Intervention group:15;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=288441
Disclaimer: Curated by HT Syndication....